Treating the hypertensive patient in a nurse-led hypertension clinic

Blood Pressure

Volumn 19, Issue 3, 2010, Pages 182-187

  Andersen, Ulla Overgaard ^a,b   Simper, Anne Marie ^a   Ibsen, Hans ^a   Svendsen, Tage Lysbo ^a  

^a Medical Department   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

Author keywords

Hypertension; Therapy

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LERCANIDIPINE; LOSARTAN; METOPROLOL; MOXONIDINE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; ALGORITHM; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CONSULTATION; COUGHING; DISEASE SEVERITY; EDEMA; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CENTER; HUMAN; HYPERTENSION; HYPERTENSION CLINIC; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL SOCIETY; NURSING PRACTICE; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; AMBULATORY CARE FACILITIES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DIURETICS; FEMALE; GUIDELINES AS TOPIC; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NURSES; PATIENT DISCHARGE; REFERRAL AND CONSULTATION; RISK FACTORS;

EID: 77952833206     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051003606405     Document Type: Article

References (12)

1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
2. Sehestedt T, Ibsen H, Jørgensen T. Awareness, treatment and control of hypertension in Denmark. The Inter99 study. Blood Press. 2007;16:312-319.
3. Kastarinen MJ, Antikainen RL, Laatikainen TK, Salomaa VV, Tuomilehto JO, Nissinen AM, et al. Trends in hypertension care in eastern and south-western Finland during 1982-2002. J Hypertens. 2006;24:829-836.
4. Cífková R, Skodová Z, Lánská V, Adámková V, Novozámská E, Petrzílková Z, et al. Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000. J Hypertens. 2004; 22:1479-1485.
5. Fahey T, Schroeder K, Ebrahim S. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database of Systematic Reviews. 2006, Issue 4. Art. No. CD005182. DOI: 10.1002/14651858. CD005182.pub.
6. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25: 1105-1187.
7. Schroeder K, Fahey T, Hollinghurst S, Peters TJ. Nurse-led adherence support in hypertension: A randomized controlled trial. Fam Pract. 2005;22:144-151.
8. Pippa Oakeshott. Nurse-led management of hypertension. Br J Gen Pract. 2005;55:53.
9. Denver EA, Barnard M, Woolfson RG, Earle KA. Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care. 2003;26:2256-2260.
10. New JP, Mason JM, Freemantle N, Teasdale S, Wong LM, Bruce NJ, et al. Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): A randomized controlled trial. Diabetes Care. 2003;26:2250-2255.
11. Mason JM, Freemantle N, Gibson JM, New JP. Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: Economic analysis of the SPLINT trial. Diabetes Care. 2005;28:40.
12. The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-1559.